Pulmonary Embolism (PE) Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about Pulmonary Embolism (PE) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE

Pulmonary Embolism (PE)
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation300 enrolled1 locationNCT07452991
Recruiting
Not Applicable

Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System

Pulmonary EmbolismAcute Pulmonary Embolism (PE)
Angiodynamics, Inc.256 enrolled1 locationNCT06697314
Recruiting
Not Applicable

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Pulmonary Embolism (PE)
RenJi Hospital127 enrolled1 locationNCT06946732
Recruiting

The Prognostic Value of Anion Gap in Predicting Mortality Among Patients With Acute Pulmonary Embolism

Acute Pulmonary Embolism (PE)
Universitas Diponegoro20 enrolled1 locationNCT06583616
Recruiting

VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Johannes Gutenberg University Mainz2,000 enrolled1 locationNCT02156401
Recruiting

The Butterfly study. A trial assessing acceptability and safety of using a subcutanous catheter to administer enoxaparin (Clexane) in patients requiring long-term therapy for treatment or prevention of blood clots.

Pulmonary Embolism (PE)Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)
Monash Health40 enrolled2 locationsACTRN12622001059752